C12N 7/045
Pseudoviral particles
Official title: {Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered}
C12N7/045 (Pseudoviral particles) appears on 51 US grants and 88 published applications in this corpus.
Search patents in C12N- Granted patents
- 51
- Published applications
- 88
- Assignees
- 70
- Inventors
- 176
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 4 | 3 |
| 2013 | 1 | 4 |
| 2014 | 1 | 4 |
| 2015 | 2 | 3 |
| 2016 | 3 | 3 |
| 2017 | 1 | 6 |
| 2018 | 1 | 11 |
| 2019 | 7 | 4 |
| 2020 | 6 | 10 |
| 2021 | 3 | 4 |
| 2022 | 10 | 6 |
| 2023 | 3 | 6 |
| 2024 | 3 | 4 |
| 2025 | 6 | 2 |
| 2026 | 0 | 10 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for constructing gE protein-deleted pseudorabies virus strain using adenine base editor and use thereof12 Aug 2025US 12,385,015 B2Jiangxi Agricultural University
- Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus20 May 2025US 12,303,560 B2Medigen, Inc.
- Recombinant adenoviruses carrying transgenes22 Apr 2025US 12,280,123 B2EpicentRx, Inc.
- Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins22 Apr 2025US 12,281,336 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Vaccinia viral vectors encoding chimeric virus like particles11 Mar 2025US 12,247,214 B2GeoVax, Inc.
- Use of prime editing in correcting mutations in cdkl520 Aug 2026US 2026/0242800 A1President and Fellows of Harvard College
- Composition including virus like particles (vlps), a kit, and method for antitumoral therapy13 Aug 2026US 2026/0234573 A1Cnpem- Centro Nacional De Pesquisa Em Energia E Materiais
- Rna-guided endonuclease system and use thereof in gene editing23 Jul 2026US 2026/0209761 A1Harbin Institute of Technology
- Systems for modulating microbiome target cells, methods and compositions thereof16 Jul 2026US 2026/0199403 A1Trobix Bio Ltd.
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
Most cited
By later US patents
- Influenza hemagglutinin and neuraminidase variants31US 8,574,593 B2MedImmune, LLC · 2013
- Virus-like particles (VLPs) prepared from chikungunya virus structural proteins30US 9,353,353 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Influenza hemagglutinin and neuraminidase variants8US 8,333,975 B2MedImmune, LLC · 2012
- Development of dengue virus vaccine components7US RE46,042 E1The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules5US 10,532,099 B2Oregon Health & Science University · 2020